Abstract:While protein coronas (PCs) are an important barrier in the clinical application of nanomedicines, the specific effects of PCs on nanoparticles (NPs) in vivo are unclear. Herein, we demonstrated that PCs from clinical sources greatly influenced the active targeting capacities of transferrin-modified NPs (Tf-NPs). Compared to PCs from healthy volunteers, PCs from the plasma of patients with nonsmall cell lung cancer (NSCLC) decreased the A549 uptake of Tf-NPs to a greater degree. The PC proteome revealed that this difference may be mediated by certain proteins in plasma. To attenuate the negative influence of PCs from patients, precoating Tf-NPs with PCs derived from healthy mice significantly enhanced active targeting capacities. Paclitaxel-loaded Tf-NPs with PCs derived from healthy mice showed the strongest antitumor effects in mice with NSCLC. This work illustrates the influence of PCs of ligand-modified NPs in clinical practice and proposes the use of corona-enabled active targeting for precision nanomedicine.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.nanolett.0c03982?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.nanolett.0c03982</a>.Details related to materials and methods; characterization of particle size and zeta (ζ) potential of bare NPs and NPs with PC (Table S1); the amount of protein adsorbed on NPs (Table S2); the most abundant proteins (top 30) identified in the PC of NPs from human sources (Table S3); the most abundant proteins (top 30) identified in the PC of NPs from murine sources (Table S4); microscopic observation of coumarin+ A549 cells (Figures S1 and S3); normalized fluorescence intensity in A549 cells (Figures S2 and S4); schematic description of the experimental design for studies of in vivo mouse PC formation (Figure S5); the intensity diameter distribution of NPs with/without in vivo mouse-derived PC (Figure S6); TEM images of NPs with/without in vivo mouse-derived PC (Figure S7); microscopy observation of coumarin+ LL/2 cells (Figures S8 and S10); the normalized fluorescence intensity in LL/2 cells (Figures S9 and S11); fluorescence intensity in organs and tumor 24 h post-injection (Figure S12); tumor size in all mouse groups (Figure S13); coomassie brilliant blue-stained SDS-PAGE gel of PCs associated with NPs (Figure S14); classification of PCs according to physiological function (Figure S15); Venn diagrams depicting the number of unique proteins identified in the in vitro-formed coronas and their respective overlap (Figure S16); Venn diagrams depicting the number of unique proteins identified in the in vivo-formed coronas and their respective overlap (Figure S17); and evaluation of NP safety and IgE concentrations in serum from all murine groups (Figure S18) (<a class="ext-link" href="/doi/suppl/10.1021/acs.nanolett.0c03982/suppl_file/nl0c03982_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Regulation of protein corona on liposomes using albumin-binding peptide for targeted tumor therapy

In situ low-immunogenic albumin-conjugating-corona guiding nanoparticles for tumor-targeting chemotherapy

Lipid-mediated protein corona regulation with increased apolipoprotein A-I recruitment for glioma targeting

Chondroitin sulfate-mediated albumin corona nanoparticles for the treatment of breast cancer

Prominent Enhancement of Peptide-mediated Targeting Efficiency for Human Hepatocellular Carcinomas With Composition-engineered Protein Corona on Gold Nanoparticles

Physicochemical and biological characterization of the lipid particles with bovine serum albumin corona

Impact of Protein Corona and PEGylation on the Accumulation and Efficacy of Lysosome-Disrupting Lipid Nanoparticles in KRAS-mutated Cancer

Endogenous Albumin-Mediated Delivery of Redox-Responsive Paclitaxel-Loaded Micelles for Targeted Cancer Therapy

Albumin As a "trojan Horse" for Polymeric Nanoconjugate Transendothelial Transport Across Tumor Vasculatures for Improved Cancer Targeting

The Effects of Serum Albumin Pre-Adsorption of Nanoparticles on Protein Corona and Membrane Interaction: A Molecular Simulation Study

Brain-targeted drug delivery by manipulating protein corona functions

The Combined Effects of Size and Surface Chemistry on the Accumulation of Boronic Acid-Rich Protein Nanoparticles in Tumors.

Lipoprotein-mimicking nanotherapeutics reconstituted with chenodeoxycholic acid modified protein for efficient tumor?targeting

Enhanced Cancer-targeted Drug Delivery Using Precoated Nanoparticles

Morphology-driven Protein Corona Manipulation for Preferential Delivery of Lipid Nanodiscs

Unraveling the Plasma Protein Corona by Ultrasonic Cavitation Augments Active-Transporting of Liposome in Solid Tumor

Insight into the Preformed Albumin Corona on in Vitro and in Vivo Performances of Albumin-Selective Nanoparticles

Lipid-conjugated siRNA hitchhikes endogenous albumin for tumor immunotherapy

Versatile Protein Coronation Approach with Multiple Depleted Serum for Creating Biocompatible, Precision Nanomedicine.

Albumin Nanoparticles Increase the Efficacy of Doxorubicin Hydrochloride Liposome Injection Based on Threshold Theory

A generalizable strategy for crosslinkable albumin-based hydrogels and application as potential anti-tumor nanoplatform